Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years

Benzinga56minutes ago

Gilead Sciences Hits 4-week High

Trading EconomicsJan 27 22:30

Goldman Sachs Adjusts Price Target on Gilead Sciences to $85 From $84, Keeps Neutral Rating

MT NewswiresJan 27 20:04 · Ratings

These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Safely

Simply Wall StJan 25 21:27

Wells Fargo Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105

Futu NewsJan 24 18:33 · Ratings

Optimistic Buy Rating for Gilead Sciences: Anticipated EPS Growth and Strong Performance in 2024

TipRanksJan 24 17:55 · Ratings